J&J-Backed Medtech Firm HistoSonics Is Said to Consider US IPO

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US initial public offering as soon as this year, according to people familiar with the matter.

The company has held discussions with investment banks as it evaluates a potential share sale that could raise a few hundred million dollars, the people said, asking not to be identified because the information is private. HistoSonics is considering seeking a valuation of several billion dollars in the listing, the people said.

A HistoSonics device

Source: HistoSonics

Deliberations are at an early stage and no final decisions have ...